Research ArticleClinical Studies

A 5% Glucose Solution for the Liquid Formulation Gemcitabine Solvent Decreases Gemcitabine-induced Vascular Pain

KAZUKI UCHIYAMA, YOSHITAKA SAITO, TATSUHIKO SAKAMOTO, YOH TAKEKUMA, YOSHITO KOMATSU and MITSURU SUGAWARA
Anticancer Research January 2022, 42 (1) 343-348; DOI: https://doi.org/10.21873/anticanres.15491

Article Information

vol. 42 no. 1 343-348
DOI 
https://doi.org/10.21873/anticanres.15491
PubMed 
34969743
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received November 5, 2021
  • Revision received November 26, 2021
  • Accepted November 29, 2021
  • Published online December 29, 2021.
Copyright & Usage 
Copyright © 2022 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Author Information

  1. KAZUKI UCHIYAMA1,
  2. YOSHITAKA SAITO1,
  3. TATSUHIKO SAKAMOTO1,
  4. YOH TAKEKUMA1,
  5. YOSHITO KOMATSU2 and
  6. MITSURU SUGAWARA1,3⇑
  1. 1Department of Pharmacy, Hokkaido University Hospital, Sapporo, Japan
  2. 2Cancer Center, Hokkaido University Hospital, Sapporo, Japan
  3. 3Laboratory of Pharmacokinetics, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan
  1. Correspondence to: Mitsuru Sugawara, Ph.D., Department of Pharmacy, Hokkaido University Hospital, Kita 14-jo, Nishi 5-chome, Kita-ku, Sapporo 060-8648, Japan. Tel: +81 117065680, Fax: +81 117067616, e-mail: msuga{at}pharm.hokudai.ac.jp
View Full Text
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
A 5% Glucose Solution for the Liquid Formulation Gemcitabine Solvent Decreases Gemcitabine-induced Vascular Pain
KAZUKI UCHIYAMA, YOSHITAKA SAITO, TATSUHIKO SAKAMOTO, YOH TAKEKUMA, YOSHITO KOMATSU, MITSURU SUGAWARA
Anticancer Research Jan 2022, 42 (1) 343-348; DOI: 10.21873/anticanres.15491
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords